𝔖 Bobbio Scriptorium
✦   LIBER   ✦

New perspectives in managing myeloproliferative disorders: focus on the patient

✍ Scribed by Gunnar Birgegård


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
71 KB
Volume
27
Category
Article
ISSN
0278-0232

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Risk stratification is the basis for treatment decisions in the chronic myeloproliferative disorders, and in addition to the three established risk factors of previous thrombosis, age and platelets >1500 × 10^9^, cardiovascular risk factors should be addressed. In addition, premorbidity with regard to possible side effects of platelet‐reducing drugs as well as the impact on quality of life of such side effects should be considered. The near‐to‐normal life expectancy and long term nature of treatment also makes it necessary to consider the potential leukaemogenic effects of some cytostatic drugs. Copyright © 2009 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


Budgeting for results: Perspectives on p
✍ Fred Thompson 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

it goes far deeper in this regard than the rest of the policy literature and than much of the scholarly literature as well. In short, How Much Is Your Vote Worth? accomplishes what it sets out to accomplish, by providing a cogent theoretical and empirical case against spending limits and public fina